2.3 Federal vs Connecticut Law (More Restrictive Rule)
Key Takeaways
- When federal and Connecticut pharmacy rules differ, the pharmacist practicing in Connecticut must satisfy both; the more restrictive rule—often Connecticut's—controls day-to-day practice, while the federal floor (DEA, FDA, HIPAA) never disappears.
- Emergency oral Schedule II follow-up is 7 days under 21 CFR 1306.11(d) but 72 hours under CGS § 21a-249(e); Connecticut's 72-hour deadline is the one you meet.
- Federal CSA law has no 7-day first-fill opioid cap; Connecticut limits first-time outpatient adult opioid prescriptions to a 7-day supply and minors to a 5-day supply (CGS § 20-14o / DCP prescribing-practice guidance).
- Connecticut has required electronic prescribing of controlled substances since 2017 (CGS § 21a-249, with emergency and technology exceptions); federal EPCS remains optional under the CSA, but if used it must meet DEA 21 CFR 1311.
- Keep controlled-substance records 3 years (CGS §§ 21a-250 and 21a-254), not the federal 2-year minimum in 21 CFR 1304.04; technician ratios and CPMRS pharmacist-access rules are Connecticut-only overlays.
The working rule on the CT MPJE
Pharmacy law questions are dual-compliance questions. Federal law (FDCA, CSA/DEA regulations, HIPAA, and related federal floors) always applies in a Connecticut pharmacy. Connecticut law (Chapters 400j, 420b, 420c, and the RCSA titles in section 2.2) also always applies. The Supremacy Clause means a state cannot authorize what federal law forbids—Connecticut cannot legalize refills of Schedule II substances, waive DEA Form 222/CSOS for CII procurement, or let a pharmacy ignore FDA adulteration rules.
What the state can do is add restrictions on top of that floor: shorter follow-up windows, extra query mandates, extra licenses, longer record retention, technician ratios, and opioid day-supply caps. The exam's working instruction is therefore:
- Identify the federal requirement.
- Identify the Connecticut requirement.
- You must satisfy both. When they differ, follow the more restrictive rule for the pharmacist practicing in Connecticut.
'Follow federal because DEA' is the most common trap when Connecticut is tighter. The opposite trap is ignoring a federal floor because a Connecticut form is complete. Neither is lawful.
How to decide which rule is 'more restrictive'
More restrictive means the rule that leaves the pharmacist less discretion or a shorter, smaller, or additional obligation: fewer days to obtain a covering prescription, fewer days of opioid supply, a mandate where federal law is optional, extra years of retention, or an extra credential (Connecticut CS registration on top of DEA). If Connecticut is silent, the federal rule is the rule. If federal law is silent (technician ratios, CPMRS pharmacist workflow), Connecticut is the rule.
Worked comparison table
| Topic | Federal floor | Connecticut rule | What you do in CT |
|---|---|---|---|
| Emergency oral Schedule II covering Rx | 7 days (21 CFR 1306.11(d)) | 72 hours after the oral order (CGS § 21a-249(e)) | Obtain the covering written or electronic prescription within 72 hours; attach it to the pharmacist's temporary Rx |
| First-fill outpatient opioid day-supply | CSA has no 7-day first-fill cap | Adult first-time outpatient: 7-day supply; minors: 5-day supply (2016/2017 laws; CGS § 20-14o; DCP prescribing-practice page) | The CT cap controls for a Connecticut-issued opioid prescription; professional-judgment exceptions in the statute still do not revive a nonexistent federal cap |
| Electronic prescribing of CS | EPCS is optional under the CSA; if used, DEA 21 CFR 1311 security applies | Generally required since 2017 (PA 17-131, CGS § 21a-249), with emergency and technology-capacity exceptions | Transmit CS electronically unless a statutory exception applies; any EPCS system must still be DEA-compliant |
| Prescription drug monitoring | No CSA pharmacist-mandate equivalent to a state PDMP query | CPMRS is DCP's PDMP; prescribers have query duties (e.g., before CII–V intended to last more than 72 hours); pharmacists may query for therapy management | Use CPMRS as Connecticut requires; do not argue that 'DEA has no PDMP, so I will not look' |
| Technician ratios | No federal community 2:1 / 3:1 scheme | RCSA 20-576-33 and 20-576-36 (and advanced-tech statute) | Follow Connecticut ratios; a DEA registration does not enlarge the tech bench |
| CS record retention | At least 2 years (21 CFR 1304.04) | 3 years for the CS prescription file (CGS § 21a-250; records also in § 21a-254) | Keep 3 years—that period also covers the federal 2-year floor |
Worked example: emergency oral CII
Federal law (21 CFR 1306.11(d)) allows a pharmacist, in a true emergency, to dispense a Schedule II substance on the oral authorization of a known or confirmed prescriber, limited to the emergency quantity, promptly reduced to writing, with a covering prescription delivered within seven days.
CGS § 21a-249(e) allows the same emergency oral CII only to the extent permitted by the federal CSA, then tightens the covering deadline: the oral order 'shall be confirmed by the proper completion and mailing or delivery' of the prescriber's prescription within seventy-two hours after the oral order. The filling pharmacist affixes the prescriber's prescription to the temporary blank and maintains both. DCP's EPCS FAQ restates the 72-hour confirmation.
Because 72 hours is shorter than 7 days, 72 hours is the Connecticut pharmacist's deadline. Waiting until day six because 'DEA allows 7 days' is a Connecticut violation even if a DEA investigator might still see a timely federal covering Rx. You cannot use the looser federal clock to excuse a missed state clock. You also cannot use the state 72-hour rule to skip federal emergency conditions (quantity limited to the emergency period, prompt reduction to writing, follow-up prescription indicating authorization of the emergency oral order).
Worked example: opioid first-fill and EPCS
The CSA does not impose a 7-day cap on a first outpatient opioid prescription. Connecticut does. DCP's prescribing-practice summary records the 2016 7-day first-time outpatient adult limit and the 2017 reduction to 5 days for minors, with the prescriber's professional judgment preserved for ongoing use as the statute allows. A stem that says 'federal law has no day limit, so fill the 30-day first-fill oxycodone for a new outpatient adult' is testing whether you will ignore CGS § 20-14o. Fill only what Connecticut allows unless a documented statutory exception applies.
On EPCS, federal law still permits written, oral, and fax CS prescriptions in the circumstances the CSA allows. Connecticut generally requires electronic transmission of controlled-substance prescriptions (2017). Emergency oral CII remains an exception, not the default. If the pharmacy's software accepts EPCS, it must still meet DEA 21 CFR 1311. State mandate plus federal security is dual compliance, not a choice.
Worked example: records, PDMP, and techs
21 CFR 1304.04 requires registrants to keep inventories and other required CS records at least two years. CGS § 21a-250 requires the proprietor to retain the CS prescription three years, readily accessible for inspection. Three years is more restrictive and is what a Connecticut pharmacy implements. Destroying CII invoices at 24 months because 'DEA only requires two' fails the state inspection even if the federal clock had run.
There is no federal pharmacist-mandate PDMP that substitutes for CPMRS. Prescriber query duties (including review before CII–V prescriptions intended to last more than 72 hours, with ongoing-treatment intervals) are Connecticut law. Pharmacists may query for medication management. 'HIPAA forbids me from looking at CPMRS' is a trap: HIPAA permits treatment-related use, and CPMRS is the state's treatment tool.
Technician ratios are purely state. Citing a DEA registration, an FDA 503A designation, or 'federal law is silent' does not authorize a fourth uncertified community technician at a 2:1 pharmacy.
Scenario drill
| Stem (short) | Wrong instinct | Correct move |
|---|---|---|
| Emergency oral oxycodone; covering Rx promised 'within a week' | Accept, because 21 CFR 1306.11 says 7 days | Require confirmation within 72 hours under § 21a-249(e) |
| First-fill adult outpatient hydrocodone 28 days | Fill it; CSA has no 7-day cap | Apply Connecticut's 7-day first-time outpatient opioid limit unless a statutory exception is documented |
| Prescriber sends a paper CII 'because DEA still allows paper' | File it as routine | Connecticut EPCS mandate applies unless an emergency or technology exception in § 21a-249 is met |
| PIC wants to shred CS files at 25 months | 'DEA two-year rule' | Retain three years under §§ 21a-250 / 21a-254 |
| New graduate staffs 4 techs per pharmacist 'because federal law doesn't set a ratio' | Silence means no limit | Apply RCSA 20-576 ratios |
When an option says 'follow the DEA rule because federal law preempts the state,' ask whether you can comply with both. If yes, and Connecticut is tighter, do the tighter thing. Preemption knocks out a state rule only when it conflicts with federal law so that simultaneous compliance is impossible—or when the state tries to authorize a federally forbidden act. Extra Connecticut restrictions are not that kind of conflict.
In a documented emergency, a Connecticut pharmacist takes an oral Schedule II order from a known prescriber. By when must the covering prescription be received?
How long must a Connecticut pharmacy keep the Schedule II–V prescriptions it fills?
A prescriber writes a first-time outpatient oxycodone prescription for a 45-year-old Connecticut adult for a 30-day supply. The pharmacist argues that the CSA has no first-fill day cap, so the 30-day quantity must be dispensed. What is the better analysis?